NPPB and heart failure: N-terminal pro–B-type natriuretic peptide (NT-proBNP), often used as a surrogate endpoint in phase II heart failure trials, warrants special mention because it has substantial variability; therefore, results from even modest-sized studies can be inconclusive or misleading.